BP821
(−)-Nicotine hydrogen tartrate salt dihydrate
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 6019-06-3
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | BP821-100-MG | In Stock | ₹ 21,401.03 |
BP821 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 21,401.03
GST (18%): ₹ 3,852.185
Total Price: ₹ 25,253.215
grade
pharmaceutical primary standard
Quality Level
100
API family
nicotine
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
InChI
1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Nicotine bitartrate dihydrate United States Pharmacopeia (USP) Reference Standard | 6019-06-3 | 400MG | -- | ₹ 47,632.80 | ||
Sigma Aldrich Fine Chemicals Biosciences Nicotine ditartrate dihydrate European Pharmacopoeia (EP) Reference Standard | 6019-06-3 | | -- | ₹ 24,531.07 | ||
Nicotine bitartrate dihydrate | -- | ₹ 24,496.98 | ||
Nicotine ditartrate dihydrate | -- | ₹ 16,107.60 | ||
6019-06-3 | Nicotine ditartrate dihydrate | -- | ₹ 890.00 - ₹ 8,099.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: (−)-Nicotine hydrogen tartrate salt dihydrate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Nicotine Resinate Medicated Chewing Gum
- Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P304 + P340 + P311 - P314
Hazard Classifications
Acute Tox. 1 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - STOT RE 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable